Christos Bakirtzis
Thessaloniki, ESYE12 54636, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Targeting the Complement-Microglia Axis for Neuroprotection in Pediatric Epilepsy.
Journal: Biomedicines
Published: June 27, 2026
Disentangling verbal learning performance in multiple sclerosis: Dissociating strategy initiation and maintenance.
Journal: The Clinical neuropsychologist
Published: May 25, 2026
OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy.
Journal: Frontiers in medicine
Published: May 14, 2026
Verbal fluency in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
Journal: Journal of clinical and experimental neuropsychology
Published: April 07, 2026
Verbal fluency in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
Journal: Journal of clinical and experimental neuropsychology
Published: April 07, 2026
Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.
Journal: Brain sciences
Published: April 03, 2026
Emotion recognition in multiple sclerosis: The influence of processing speed and cognitive reserve.
Journal: Journal of neuropsychology
Published: April 02, 2026
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 20, 2026
A neurologist's guide to VEXAS syndrome: Differentiating somatic autoinflammation from autoimmune mimics.
Journal: Intractable & rare diseases research
Published: February 05, 2026
Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.
Journal: Frontiers in public health
Published: February 01, 2026
The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 13, 2025
Last Updated: 09/26/2026